Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.69 |
| ▸ | POLB | P06746 | 1/20 | 0.62 |
| ▸ | NOD1 | Q9Y239 | 8/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | DGKA | P23743 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | FAAH | O00519 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.48 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.48 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3766835 | 1.00 | KMT2A (0.69) | KMT2APOLBNOD1L3MBTL1DGKA | |
| SCHEMBL9801697 | 0.97 | KMT2A (0.69) | KMT2APOLBNOD1L3MBTL1DGKA | |
| SCHEMBL9801689 | 0.97 | KMT2A (0.69) | KMT2APOLBNOD1L3MBTL1DGKA | |
| SCHEMBL27934172 | 0.97 | KMT2A (0.69) | KMT2APOLBNOD1L3MBTL1DGKA | |
| SCHEMBL3766774 | 0.97 | KMT2A (0.69) | KMT2APOLBNOD1L3MBTL1DGKA | |
| SCHEMBL8526564 | 0.97 | KMT2A (0.69) | KMT2APOLBNOD1L3MBTL1DGKA | |
| SCHEMBL3766782 | 0.97 | KMT2A (0.69) | KMT2APOLBNOD1L3MBTL1DGKA | |
| SCHEMBL27846793 | 0.97 | KMT2A (0.69) | KMT2APOLBNOD1L3MBTL1DGKA | |
| SCHEMBL8526560 | 0.97 | KMT2A (0.69) | KMT2APOLBNOD1L3MBTL1DGKA | |
| SCHEMBL27724371 | 0.97 | KMT2A (0.69) | KMT2APOLBNOD1L3MBTL1DGKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-57202360-A | — | — | None | — | — | JP | disclosed |
| US-7850955-B2 | contain a specific N-acylamino acid monoamide monoalkyl ester; do not cause sweating while retaining a practical level of gel strength; good spreadability, and good fittability to skin; antiperspirants | AJINOMOTO CO., INC. (JP) | 2010-12-14 | — | — | US | disclosed |
| US-20080311164-A1 | GELLING AGENT | AJINOMOTO CO. INC (JP) | 2008-12-18 | — | — | US | disclosed |
| JP-S57202360-A | EMULSION TYPE COLORANT COMPOSITION | SAKURA COLOR PROD CORP | 1982-12-11 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080311164-A1 | GELLING AGENT | CUTA, NAAA, ASIC1 | KMT2A 616/4885POLB 2341/4885NOD1 3559/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.